Get involved

Claim

Opening the claim…

The FDA's medical reviews list 16 of those adult trials (8,487 participants) among the studies of the approval programmes whose data the re-analyses of FDA data used, and in them serious suicidal behaviour affected 7 to 9 participants on antidepressants and 1 on placebo. In the 304 comparisons that neither those data nor, by drug and date, the FDA's 2006 adult data could hold (62,652 participants), it affected 36 to 37 against 15 to 18 (risk ratio 1.64 to 1.98; p 0.030 to 0.097), and with the trials' public reports 36 against 16 to 17 (1.73 to 1.83; p 0.0497 to 0.070). · sciencejournal.ai